Login / Signup

Preclinical studies indicate that INFLATIV, an herbal medicine cream containing Pereskia aculeata, presents potential to be marketed as a topical anti-inflammatory agent and as adjuvant in psoriasis therapy.

Nícolas de Castro Campos PintoMariana de Souza Ferreira MacielNathalia Dos Santos RezendeAna Paula do Nascimento DuqueRenata de Freitas MendesJucélia Barbosa da SilvaMonique de Rezende EvangelistaLuana Cahon MonteiroJosiane Mello da SilvaJuliana de Carvalho da CostaElita Scio
Published in: The Journal of pharmacy and pharmacology (2020)
The results demonstrated the relevant therapeutic and marketing potentials of INFLATIV, which is likely to be further evaluated in clinical trials for drug registration process with regulatory agencies.
Keyphrases
  • clinical trial
  • anti inflammatory
  • early stage
  • cell therapy
  • transcription factor
  • case control
  • phase ii
  • human health
  • stem cells
  • wound healing
  • emergency department
  • study protocol
  • hidradenitis suppurativa